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Trypsin-like activityImmunoproteasomes are alternative forms of proteasomes specialized in the generation of MHC class I antigenic
peptides and important for efﬁcient cytokine production. We have identiﬁed a new biochemical property of 26S
immunoproteasomes, namely the ability to hydrolyze basic proteins at greatly increased rates compared to
constitutive proteasomes. This enhanced degradative capacity is speciﬁc for basic polypeptides, since substrates
with a lower content in lysine and arginine residues are hydrolyzed at comparable rates by constitutive and
immunoproteasomes. Crucially, selective inhibition of the immunoproteasome tryptic subunit β2i strongly
reduces degradation of basic proteins. Therefore, our data demonstrate the rate limiting function of the
proteasomal trypsin-like activity in controlling turnover rates of basic protein substrates and suggest new biolog-
ical roles for immunoproteasomes inmaintaining cellular homeostasis by rapidly removing a potentially harmful
excess of free histones that can build up under different pathophysiological conditions.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The 26S proteasome is an ATP-dependent protease that is responsi-
ble for the degradation of the majority of cellular proteins in eukaryotic
cells. This multi-subunit complex consists of the 20S proteasome, in
which proteins are degraded, and one or two 19S regulatory particles,
which are responsible for recognizing, unfolding, and translocating
polyubiquitinated substrates into the 20S internal proteolytic cavity
[1]. The 20S proteasome is a barrel-shaped structure composed of four
stacked heptameric rings. The two outer rings consist of α-subunits,
while the two central rings are made up of β-subunits. Three of the
subunits in the β rings (β1, β2, and β5) contain the proteolytic active
sites that are positioned on the interior face of the cylinder. Proteolytic
activities of proteasomes measured using short ﬂuorogenic substrates
have deﬁned three distinct cleavage preferences:β1has caspase activity
(i.e. cleaving after acidic residues); β2 possesses tryptic activity
(i.e. cleaving after basic residues); andβ5 displays chymotryptic activity
(i.e. cleaving after hydrophobic residues). Lymphoid cells and cells ex-
posed to cytokines such as interferon-γ (IFN-γ) or tumor necrosis factor
(TNF)-α express three homologous subunits (β1i/LMP2, β2i/MECL-1,
β5i/LMP7) that replace the constitutive ones in newly assembled,
so-called immunoproteasome particles [2].Sciences, University of Turin,
+39 0116709109; fax: +39Experiments with small ﬂuorogenic substrates have shown that
immunoproteasomes have a greater capacity to cleave after hydropho-
bic and basic residues, and a lower capacity to cleave after acidic
residues. Consequently, peptides generated by immunoproteasomes
should have a higher percentage of hydrophobic and basic C-termini,
both of which favor uptake by TAP transporters and which are essential
for tight binding to MHC class I molecules [3]. Furthermore, this altered
cleavage speciﬁcity may also enhance the production of longer precur-
sors to the MHC-presented peptide without affecting the overall size
distribution of proteasomal products [4]. Although there are examples
of epitopes that are generatedwith lower efﬁciency, orwhich are not re-
leased by immunoproteasomes, thepivotal role of immunoproteasomes
in the generation of the vast majority of MHC class I ligands was deﬁn-
itively demonstrated in transgenic mice lacking all three proteasomal
catalytic β-immune subunits [5]. Additionally, immunoproteasomes
have been shown to be important for efﬁcient cytokine production [6]
and have been implicated in a number of pathological disorders such
as cancer and neurodegenerative and autoimmune diseases [7–9].
Recently, immunoproteasomes were reported to play a major role
in protecting cell viability under cytokine-induced oxidative stress
due to their enhanced capacity to degrade nascent, oxidant-damaged
polyubiquitinated proteins [10], although subsequent studies failed to
conﬁrm these data [11].
Our previous studies have shown that oxidized ovalbumin is degrad-
ed in vitro with comparable efﬁciency by both constitutive and immuno
20S and 26S proteasomes [4]. However, additional data concerning the
effects of the INF-γ-induced subunits on the hydrolysis rates of non-
ubiquitinated proteins are not available. To address this, we investigated
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loosely folded proteins that are hydrolyzed in vitro by 26S proteasomes
in a linear, ATP-dependent manner, without ubiquitination [12]. In this
way, we discovered that compared to constitutive proteasomes, 26S
immunoproteasomes exclusively degrade at greatly enhanced rates
proteins that are characterized by an exceptional high content in basic
residues. We further demonstrated that the proteasomal tryptic site
has a rate limiting function in controlling turnover rates of basic proteins
and suggested potentially new roles of immunoproteasomes in catalyz-
ing the rapid removal of histones.
2. Methods
2.1. Proteasome puriﬁcation
26S proteasomes and immunoproteasomes were puriﬁed from rab-
bit muscle and spleen, respectively (Pel Freez Biologicals, Rogers, AR,
USA), as described previously [4,13] and are free of aminopeptidases
that may act on proteasome products.
2.2. Protein degradation and peptide analysis
Protein degradation, analysis of new amino groups using
ﬂuorescamine, and HP-SEC analysis were performed as previously de-
scribed [4,12,14,15]. More details are provided in the Supplementary
Materials and Methods.
3. Results
3.1. Enhanced rates of breakdown of basic proteins by the 26S
immunoproteasome
Incorporation of INF-γ-induced β subunits signiﬁcantly modiﬁes pro-
teasome peptidase activities [2]. Accordingly, 26S immunoproteasomes
show an enhanced capacity to cleave short ﬂuorogenic peptides on the
carboxyl side of both basic (Fig. S1A) and hydrophobic (Fig. S1B) residues
and a reduced ability to cleave after acidic amino acids (Fig. S1C). Specif-
ically, the incorporation of INF-γ-induced subunits increases themaximal
rate (Vmax) at which proteasomes hydrolyze the basic substrates Z-ARR-
amc, Boc-LRR-amc, and Bz-VGR-amc by two to threefold, and the
hydrophobic substrate AFF-amc by more than sevenfold, while it
reduces the Vmax of the degradation of the acidic peptide Suc-YVAD-
amc by about one-half (Table 1). Notably, in the case of the caspase site
of immunoproteasomes, at a reduced maximum velocity the Km value
increases by nearly fourfold (Table 1). In contrast, the difference in Km
between constitutive and immunoproteasomes is much lower for the
chymotrypsin-like activity, while for the trypsin-like activity it seems to
mainly depend on the substrate utilized (Table 1).Table 1
Kinetics parameters for the degradation of different ﬂuorogenic peptides by 26S
proteasomes and immunoproteasomes.
Substrate 26S proteasomes
Immuno Constitutive
Vmax (nmol/mg∗min) Km (μM) Vmax (nmol/mg∗min) Km (μM)
Bz-VGR-amc 379 ± 33 1801 ± 319 120 ± 11 665 ± 171
Z-ARR-amc 115 ± 3 668 ± 33 51 ± 3 493 ± 61
Boc-LRR-amc 247 ± 17 573 ± 65 127 ± 10 697 ± 82
AAF-amc 116 ± 25 170 ± 53 15 ± 4 139 ± 57
Suc-YVAD-amc 12 ± 3 503 ± 167 23 ± 2 127 ± 33
Maximum velocity (Vmax) and Michaelis–Menten constant (Km) were calculated as
described in Materials and Methods from the data shown in Supplementary Fig. S1.
Values are mean ± SE.Maximum velocity (Vmax) and Michaelis–Menten constant (Km)
were calculated as described in Materials and Methods from the data shown in
Supplementary Fig. S1. Values are mean ± SE.A more relevant question, however, is to understand how these dif-
ferences in peptidase activity, unveiled by the use of short ﬂuorogenic
peptides, relate to the true process of protein degradation and, speciﬁ-
cally, whether they inﬂuence the overall rates of protein breakdown
by proteasomes. To address this point, we studied in vitro degradation
by 26S constitutive and immunoproteasomes of IGF-1, casein and his-
tones by measuring the appearance of new amino groups generated
as a consequence of hydrolysis of the substrate with ﬂuorescamine.
Casein and histones have little tertiary structure and are degraded by
puriﬁed 26S proteasomes without ubiquitylation at linear rates for
several hours in the presence of ATP [12,15]. On the contrary, IGF-1 re-
quires preliminary denaturation by reduction of disulﬁde bonds and
carboxymethylation of the cysteins in order to be hydrolyzed in vitro
by 26S proteasomes in an ATP-dependent but ubiquitin-independent
manner [15]. As shown in Fig. 1a, IGF-1 and casein were hydrolyzed
by 26S constitutive and immunoparticles at linear, identical rates, thus
conﬁrming ﬁndings previously reported for ovalbumin with other two
model proteasome substrates [4]. In contrast, the results obtained
for the hydrolysis of H1, the linker histone in chromatin protects
internucleosomal DNA, were unexpected. In fact, this extremely basic
substrate was degraded six times faster by immuno- than by constitu-
tive 26S proteasomes (Fig. 1b). Importantly, a four-fold increase in
histone concentration did not modify the rates of H1 degradation, thus
demonstrating that in these experiments both proteasomal species
were catalyzing the hydrolysis reaction at maximum velocity (i.e. in
conditions of substrate saturation) (Fig. S2).
These results were subsequently conﬁrmed by directly comparing
the rates of substrate consumption. Towards this end, histone H1 was
incubated with 26S constitutive or immunoproteasomes and the
amount of undegraded protein present at different time points was
quantiﬁed. In agreement with the ﬂuorescamine data, these experi-
ments clearly revealed the greatly increased rates of histone H1
hydrolysis by 26S proteasomes containing INF-γ-induced β-subunits
(Fig. 1c). The enhanced capacity of immunoproteasomes to hydrolyze
basic proteins was subsequently conﬁrmed by assessing the rates of
degradation of the core histones H2A, H2B, and H3. Similarly to histone
H1, these substrates were also degraded at rates that were about four-
fold higher by proteasome containing immune β-subunits compared
to regular 26S particles (Figs. 2a, b and S3). This enhanced capacity of
immunoproteasomes to hydrolyze proteins rich in lysine and arginine
was subsequently conﬁrmed by assessing degradation of another
completely unrelated basic substrate, namely myelin basic protein
(MBP). Similar to histones and casein, MBP has very little tertiary struc-
tures and therefore can be degraded by proteasomes without the need
for ubiquitination [16,17]. As shown in Figs. 3 and S4, MBP was also
degraded about four-fold faster by 26S immuno- than by 26S constitu-
tive proteasomes. Taken together, these results clearly demonstrate
that highly basic proteins are hydrolyzed with higher efﬁciency by
immunoproteosomes than by constitutive proteasomes.
The rate limiting role of immunoproteasome tryptic activity in
determining the rate of hydrolysis of basic proteinswas subsequently in-
vestigated using leupeptin, a competitive inhibitor that was reported to
speciﬁcally inactivate the β2 subunit of constitutive proteasomes [12].
Preliminary experiments using ﬂuorogenic peptides indeed showed
that leupeptin is able to block theβ2i subunit of 26S immunoproteasome
with high efﬁciency without effecting β1i and β5i sites (Table 2).
Having established conditions that allow selective inhibition of the
tryptic site of the immunoproteasome in the absence of any detect-
able effects on the other two peptidase activities, we analyzed the
effect of leupeptin on hydrolysis of histones and MBP. As shown in
Fig. 4, leupeptin consistently decreased the degradation of these
basic proteins by about 40%. Although incomplete, the inhibition
obtained with a competitive inhibitor that speciﬁcally targets only
the β2i subunit unambiguously demonstrates the rate limiting role
of immunoproteasome tryptic activity in controlling the turnover
rates of basic proteins.
Fig. 1. Enhanced rates of histone H1 hydrolysis, but not of IGF-1 and casein, by 26S immunoproteasomes. IGF-1 and casein (a) and histone H1 (b) were incubated with 26S proteasomes
and immunoproteasomes and the amino groups releasedwere measured with ﬂuorescamine at the indicated time points. Data are representative of three independent experiments. NS,
not signiﬁcant. * P b 0.05. (c) Undegraded H1 present at different time points was separated by SDS-PAGE and quantiﬁed by densitometric analysis. Data are the average of three
independent experiments ± SEM. ** P b0.005.
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of proteasomal products
In principle, the faster rate of degradation of basic proteins by 26S
immunoproteasomes should result in enhanced fragmentation of theFig. 2. Enhanced rates of core histone degradation by 26S immunoproteasomes. (a) Core his-
tones H2A, H2B, and H3 were incubated with 26S proteasomes and immunoproteasomes
and the undegraded proteins separated by SDS-PAGE. (b) Densitometric quantiﬁcation of
residual proteins. Data are the average of three independent experiments ± SEM.
*** P b0.0005.substrate into smaller products. To test this hypothesis, we analyzed
the size distribution of products generated by hydrolysis of H1 on a
HP-size exclusion chromatographic method recently developed by our
group that allows linear separation and accurate quantiﬁcation of pep-
tides in the range of 1 to 40 residues [13,14]. In particular, the protein
was degraded under conditions ensuring that peptides released by
26S proteasomes do not re-enter the degradative particle and therefore
are not subjected to a second round of hydrolysis (i.e. the substrate was
present in large excess and not more than 10% was degraded at the
end of the incubation, Fig. S5). The analysis of the size distribution ofFig. 3. Enhanced rates ofMBP hydrolysis by 26S immunoproteasomes.MBPwas incubated
with 26S proteasomes and immunoproteasomes, and the amino groups released were
measured using ﬂuorescamine at the indicated time points. Data are representative of
three independent experiments. * P b 0.05.
Table 2
Effect of leupeptin on peptidase activities of 26S immunoproteasomes.
Activity 100 μM leupeptin (% inhibition)
Chymotrypsin-like 0
Caspase-like 0
Tryptic-like 97.6 ± 0.4
Chymotrypsin-like, caspase-like and trypsin-like of 26S immunoproteasomes were
assessed using Z-GGL-amc, Suc-YVAD-amc and Bz-VGR-amc (100 μM each) in the
presence or absence of leupeptin. Data are the means of three independent
measurements ± SE.
Fig. 5. Same size distribution of peptides generated during hydrolysis of H1 by 26S
proteasomes and immunoproteasomes. (a) Size distribution of peptides generated from
H1 by 26S proteasomes and immunoproteasomes. Equal amounts of peptides generated
during degradation of H1 were reacted with ﬂuorescamine and immediately fractionated
by HP-SEC. Similar data were obtained in four independent experiments. (b) Mean sizes
and medians were calculated from the distributions of products obtained by HP-SEC.
Values are averages from four experiments ± SEM. NS, not signiﬁcant.
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ed that 26S immunoproteasomes do not generate increased amounts
of shorter products (Fig. 5a and b). This disproves the hypothesis that
proteins rich in basic residues are fragmentized into smaller pieces by
proteasome variants displaying enhanced trypsin-like peptidase activity.
4. Discussion
Chymotrypsin-like activity of proteasomes has been generally
viewed as the most important and rate-limiting step in protein break-
down in vivo [18]. This notion, however, was challenged in a study by
Kisselev demonstrating that the relative contributions of the three
proteasomal proteolytic sites depend on the protein being degraded
and its amino acid composition [12]. Accordingly, in this study, the
importance of trypsin-like activity was found to strongly correlate
with the content in basic amino acids of the substrate. It is unclear,
however, whether and to what extent the different susceptibility ofFig. 4. Selective inhibition of the trypsin-like activity of 26S immunoproteasomes slows the hydrolysis of basic proteins. Histones H1 (a), H2/H3 (b) andMBP (c) were incubatedwith 26S
immunoproteasomes in the presence or absence of 100 μM leupeptin and the amino groups released weremeasured with ﬂuorescamine at the indicated time points. Data are represen-
tative of three independent experiments. * P b 0.05.
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sites affects the overall rate of substrate degradation by proteasomes.
This question is especially relevant in the case of immunoproteasomes,
where the constitutive catalytic β-subunits are replaced by new ones
that display highly modiﬁed peptidase speciﬁcities. To address this
point, we studied degradation of several naturally (casein, histones
and MBP) or artiﬁcially (carboxymethylated IGF-1) loosely folded
proteins that are hydrolyzed in an ATP-dependent linear manner in the
absence of ubiquitination by 26S constitutive and immunoproteasomes.
In this way, we were able to demonstrate that despite the clear differ-
ences in peptidase activities seen with short ﬂuorogenic peptides, 26S
constitutive and immunoproteasomes degrade neutral IGF-1 (pI 7.4)
and moderately acidic casein (pI 5.2) at the same rates. These results
obtained with two widely used proteasomal model substrates conﬁrm
our previous data showing that oxidized ovalbumin is degraded in vitro
with comparable efﬁciency by 26S constitutive and immunoproteasomes
[4]. For these substrates, therefore, it seems likely that the rates of
hydrolysis do not simply depend on the efﬁciency of peptide bonds
cleavage at proteasomal active sites, while other factors (e.g. the afﬁnity
of the protein for the regulatory 19S particle and/or the velocity of its
translocation into the proteolytic internal chamber) are crucial and prob-
ably represent rate-limiting steps of the degradation process. In this
respect, the observation that breakdown rates by 26Sproteasomes of sev-
eral unfolded proteins inversely correlate with their molecular weights
(Fig. 1 and [15]) is of interest, as it suggests that shorter polypeptides
might interact with higher afﬁnity with the 19S cap and/or diffuse faster
through the α-pore of the 20S core particle. At present, we cannot ex-
clude the possibility that proteins extraordinarily rich in hydrophobic res-
idues are hydrolyzed at enhanced rates by 26S immunoproteasomes.
However, the elevated tendency to aggregate and precipitate, together
with their tightly folded structure, precludes the use of such substrates
in degradation experiments such as those performed herein. In accor-
dance with our conclusions, Kisselev was unable to establish any correla-
tion between the content of hydrophobic residues and the degree of
proteolytic inhibition seen upon inactivation of the chymotrypsin-like
site for four proteins investigated, including ovalbumin and casein [12].
Completely different results were obtained when we assessed the
degradation of substrates characterized by an unusually high con-
tent in lysine and arginine such as histones and MBP. In fact, these
extremely basic proteins (H1 pI 11.4, H2A pI 11.3, H2B pI 10.8, H3 pI
11.5, MBP pI 11.1) were hydrolyzed at 4–6 fold higher rates by 26S
immunoproteosomes than by constitutive proteasomes. Notably, this
unexpected difference in breakdown rates cannot be ascribed merely
to a difference in the afﬁnity of substrates for the two variants of
proteasomes (i.e. to a difference in their Km), since an increase in the
concentrations of substrates does not further enhance their degrada-
tion. This demonstrates that under the experimental conditions used
both 26S proteasomes and immunoproteasomes are acting at maxi-
mum velocity. In contrast, the higher rates of basic protein degradation
are likely to directly depend on the enhanced trypsin-like activity of
immunoproteasomes, as suggested by the observation that the lower
rates of breakdown of histone H1 by constitutive 26S proteasomes are
comparable to those measured for a substrate of similar molecular
mass such as casein (panels A and B in Fig. 1). It seems likely, therefore,
that in the case of extremely basic protein substrates the overall rates of
proteasomal hydrolysis are mainly determined by the efﬁciency of pep-
tide bond cleavage at the tryptic site. Accordingly, the enhanced trypsin-
like activity caused by replacement of the constitutive β2 subunit with
the INF-γ-induced variant β2i could account for the higher hydrolytic
capacity of 26S immunoproteasomes towards histones and MBP.
This hypothesis was directly tested using leupeptin, a competitive
inhibitor that has been reported to selectively suppress the trypsin-
like activity of proteasomes [12], and which we showed is effective in
inactivating the β2i subunit without effecting β1i and β5i. Crucially,
in our experiments leupeptin was capable of effectively slowing the
hydrolysis by 26S immunoproteasomes of all basic proteins tested, thusdemonstrating the rate limiting function of the β2i subunit in determin-
ing turnover rates of basic substrates. In this regard, it should be stressed
that the incomplete inhibition of basic protein degradation seen with
leupeptin was somewhat expected considering its competitive mecha-
nism of action. In fact, it is not surprising that leupeptin cannot complete-
ly prevent binding at the β2i active site of protein stretches rich in lysine
and arginine, which are likely to present a strong afﬁnity to the tryptic
site and reach a high concentration in the small volume of the internal
proteasomal cavity. Interestingly, the increased rate of peptide bond
cleavage at the β2i subunit does not alter the size distribution of products
generated from histones. Therefore, it is likely that the number of cleav-
ages made by proteasomes in a polypeptide depends on the intrinsic
properties of the particle (rather than on the catalytic efﬁciency of active
sites). This is also demonstrated by the lack of difference in the size distri-
bution of peptides generated when an active site is inhibited [15,19].
It was recently reported that during somatic DNA damage response
and spermatogenesis core histones (but not the linker histone H1) are
preferentially degraded by special forms of proteasomes containing
the activator PA200 in an acetylation, but not polyubiquitination-
dependent, process [20]. Furthermore, testes were found to express
high levels of INF-γ-induced β-subunits, thus indicating a speciﬁc role
of immunoproteasomes in the hydrolysis of histones during spermato-
genesis. Moreover, during transcription, histones are removed from
DNA at promoter regions or active gene bodies in somatic cells
[21,22], and several lines of evidence suggest that the released histones
are rapidly degraded by proteasomes even in the absence of
ubiquitination [23]. Our data showing that in vitro histones are hydro-
lyzed by 26S proteasomeswith no need for polyubiquitination, in a pro-
cess that is strongly acceleratedwhen the INF-γ-induced β-subunits are
incorporated, have important implications in fully understanding all the
possible biological functions of immunoproteasomes. Following stimu-
lation of mammalian cells with pro-inﬂammatory cytokines such as
interferon-γ or TNF-α, several regulatory pathways are activated that
rely on the rapid transcription of hundreds of different genes [24].
In this situation, the accumulation of histones released from sites of
active transcription might be harmful for the cell [25]. The rapid
formation of immunoproteasomes induced by several cytokines may,
therefore, be useful to efﬁciently remove non-chromatin bound his-
tones, thus preventing genomic instability, hypersensitivity to DNA
damaging agents, and blocking transcription caused by accumulation
of these basic proteins [25]. In agreement with this hypothesis,
immunoproteasomes were recently shown to play a speciﬁc role in
the control of cytokine production and T cell differentiation [26]. More-
over, it appears unlikely that immunoproteasomes evolved exclusively
to improve generation of class I epitopes sinceMHC-I molecules accom-
modate peptides with basic residues at their C-terminus only occasion-
ally in humans and never in mice [6]. Accordingly, no decrease in cell
surface expression of MHC class I molecules was observed in β2i-
deﬁcient mice [27]. Intriguingly, β2i is the only cytokine-induced
proteasomal subunit to be encoded outside the MHC region [2,3]. Al-
though recently generated mice lacking all three immunoproteasomal
catalytic subunits are viable and apparently healthy [5], previous studies
detected a 20–30% decrease in the number of CD8+ T in the thymus,
blood, and spleen of β2i-deﬁcient mice [27]. Importantly, this decrease
does not correlate with MHC class I expression but, rather, it seems
that CD8+ T cells β2i−/− expand less readily than wild-type CD8+ [6].
This highlights that there is a requirement for immunoproteasomes
(and speciﬁcally the β2i subunit) for the survival of T cells in a pro-
inﬂammatory environment.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.05.005.
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